Nephros, Inc. (NASDAQ:NEPH) Short Interest Update

Nephros, Inc. (NASDAQ:NEPH) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 19,400 shares, an increase of 133.7% from the February 28th total of 8,300 shares. Based on an average trading volume of 13,500 shares, the days-to-cover ratio is currently 1.4 days. Approximately 0.2% of the company’s shares are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC bought a new position in shares of Nephros, Inc. (NASDAQ:NEPH) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned 3.98% of Nephros at the end of the most recent reporting period. Hedge funds and other institutional investors own 41.10% of the company’s stock.

Nephros Price Performance

Shares of NEPH stock opened at $1.67 on Friday. The stock has a market capitalization of $17.61 million, a PE ratio of -18.56 and a beta of 1.19. The business’s 50 day simple moving average is $1.57 and its 200 day simple moving average is $1.57. Nephros has a one year low of $1.36 and a one year high of $2.55.

Nephros (NASDAQ:NEPH) last posted its quarterly earnings data on Monday, March 24th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. Nephros had a negative net margin of 6.86% and a negative return on equity of 11.39%. The company had revenue of $3.87 million for the quarter, compared to analyst estimates of $3.67 million.

Nephros Company Profile

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.